78 related articles for article (PubMed ID: 20632326)
1. Clinical significance of flow cytometry in detection of minimal residual disease in cerebrospinal fluid.
Luo Y; Lin T; Xian L; Zhao Y; Li W; Liu J; Lan M; Shan H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1838-1843. PubMed ID: 38448377
[TBL] [Abstract][Full Text] [Related]
2. Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Gökbuget N; Boissel N; Chiaretti S; Dombret H; Doubek M; Fielding A; Foà R; Giebel S; Hoelzer D; Hunault M; Marks DI; Martinelli G; Ottmann O; Rijneveld A; Rousselot P; Ribera J; Bassan R
Blood; 2024 May; 143(19):1903-1930. PubMed ID: 38306595
[TBL] [Abstract][Full Text] [Related]
3. Minimal residual disease monitoring in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia: prognostic significance and correlation between multiparameter flow cytometry and real-time quantitative polymerase chain reaction.
Li J; Lu A; Gao Y; Wan Y; Wang J; Zhang J; Hu T; Wu P; Chen X; Zou Y; Chen Y; Zhang L; Guo Y; Yang W; Li C; Zhang Y; Zhu X
Haematologica; 2024 May; ():. PubMed ID: 38695139
[TBL] [Abstract][Full Text] [Related]
4. Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.
Chatterjee G; Gujral S; Subramanian PG; Tembhare PR
Indian J Hematol Blood Transfus; 2017 Sep; 33(3):303-315. PubMed ID: 28824230
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system.
Basso-Ricci L; Scala S; Milani R; Migliavacca M; Rovelli A; Bernardo ME; Ciceri F; Aiuti A; Biasco L
Cytometry A; 2017 Oct; 91(10):952-965. PubMed ID: 28609016
[TBL] [Abstract][Full Text] [Related]
6. Current Strategies for the Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
Rocha JM; Xavier SG; de Lima Souza ME; Assumpção JG; Murao M; de Oliveira BM
Mediterr J Hematol Infect Dis; 2016; 8(1):e2016024. PubMed ID: 27158437
[TBL] [Abstract][Full Text] [Related]
7. Detection of minimal residual disease in B lymphoblastic leukemia using viSNE.
DiGiuseppe JA; Tadmor MD; Pe'er D
Cytometry B Clin Cytom; 2015; 88(5):294-304. PubMed ID: 25974871
[TBL] [Abstract][Full Text] [Related]
8. Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches.
Salari F; Shahjahani M; Shahrabi S; Saki N
Med Oncol; 2014 Nov; 31(11):266. PubMed ID: 25287907
[TBL] [Abstract][Full Text] [Related]
9. Measurements of treatment response in childhood acute leukemia.
Campana D; Coustan-Smith E
Korean J Hematol; 2012 Dec; 47(4):245-54. PubMed ID: 23320002
[TBL] [Abstract][Full Text] [Related]
10. Should minimal residual disease monitoring in acute lymphoblastic leukemia be standard of care?
Campana D
Curr Hematol Malig Rep; 2012 Jun; 7(2):170-7. PubMed ID: 22373809
[TBL] [Abstract][Full Text] [Related]
11. Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study.
Holowiecki J; Krawczyk-Kulis M; Giebel S; Jagoda K; Stella-Holowiecka B; Piatkowska-Jakubas B; Paluszewska M; Seferynska I; Lewandowski K; Kielbinski M; Czyz A; Balana-Nowak A; Król M; Skotnicki AB; Jedrzejczak WW; Warzocha K; Lange A; Hellmann A
Br J Haematol; 2008 Jun; 142(2):227-37. PubMed ID: 18492099
[TBL] [Abstract][Full Text] [Related]
12. Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
Campana D; Coustan-Smith E
Best Pract Res Clin Haematol; 2002 Mar; 15(1):1-19. PubMed ID: 11987913
[TBL] [Abstract][Full Text] [Related]
13. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.
Gaipa G; Basso G; Biondi A; Campana D
Cytometry B Clin Cytom; 2013; 84(6):359-69. PubMed ID: 23757107
[TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of two flow cytometry methodologies for monitoring minimal residual disease in a multicenter treatment protocol of childhood acute lymphoblastic leukemia.
Luria D; Rosenthal E; Steinberg D; Kodman Y; Safanaiev M; Amariglio N; Avigad S; Stark B; Izraeli S;
Cytometry B Clin Cytom; 2010 Nov; 78(6):365-71. PubMed ID: 20632326
[TBL] [Abstract][Full Text] [Related]
15. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
Chen JS; Hsiao CC; Sheen JM; Cheng CN
Leuk Res; 2007 Oct; 31(10):1351-7. PubMed ID: 17445885
[TBL] [Abstract][Full Text] [Related]
16. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
